P-Values

Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.

At P-Values, you’ll find updates, perspective, insights and information from staff and partners working on the frontlines of research, advocacy and implementation. P-value is a statistical term for the probability that a trial result is reliable and not the outcome of chance. 

Featured

Blog Post

Global Health Watch: Legacies of Parton & Goosby, expiring global health funds, Jeremy Lewin’s move, Ebola funding & vaccine R&D

This week, the global health community lost a powerful, if unlikely, champion in Dolly Parton. Longtime leader Eric Goosby, who served as the US Global AIDS Coordinator and led the President’s Emergency Plan for AIDS Relief (PEPFAR) from 2009 to 2013 under President Barack Obama, officially retired this week. Also this week, members of the US Congress demanded that the Administration release billions in congressionally-appropriated global health funding; another leadership change is underway at the Department of State; and in the DRC, the Ebola response is making progress even as inadequate funding threatens efforts.

Read more

Blog Post

Global Health Watch: NIH reopens South Africa Research Funding; DRC Ebola Strains Outbreak Response; WHO + FDA Leadership Shifts

The US National Institutes of Health (NIH) lifted research funding restrictions on South Africa; the DRC’s Ebola outbreak grows, exposing the consequences of weakened outbreak-response systems; and leadership changes at the World Health Organization (WHO) and the US Food and Drug Administration (FDA) raise questions about the future of global health decision-making.

Read more

Blog Post

The Latest Resources from AVAC: Advancing Science, Expanding Access

Scientific breakthroughs accelerate HIV prevention—but only when they are matched with bold advocacy, sustained investment and equitable access. This month’s roundup highlights key prevention news, developments and takeaways from AVAC and explores what’s needed and what’s next to ensure the latest innovations move beyond headlines and into the hands of the communities that need them most.

Read more

Filter by

Reset filters

P-Values

showing 1-10 of 1259

Global Health Watch: Legacies of Parton & Goosby, expiring global health funds, Jeremy Lewin’s move, Ebola funding & vaccine R&D

This week, the global health community lost a powerful, if unlikely, champion in Dolly Parton. Longtime leader Eric Goosby, who served as the US Global AIDS Coordinator and led the President’s Emergency Plan for AIDS Relief (PEPFAR) from 2009 to 2013 under President Barack Obama, officially retired this week. Also this week, members of the US Congress demanded that the Administration release billions in congressionally-appropriated global health funding; another leadership change is underway at the Department of State; and in the DRC, the Ebola response is making progress even as inadequate funding threatens efforts.

August 2026

Global Health Watch: NIH reopens South Africa Research Funding; DRC Ebola Strains Outbreak Response; WHO + FDA Leadership Shifts

The US National Institutes of Health (NIH) lifted research funding restrictions on South Africa; the DRC’s Ebola outbreak grows, exposing the consequences of weakened outbreak-response systems; and leadership changes at the World Health Organization (WHO) and the US Food and Drug Administration (FDA) raise questions about the future of global health decision-making.

August 2026

The Latest Resources from AVAC: Advancing Science, Expanding Access

Scientific breakthroughs accelerate HIV prevention—but only when they are matched with bold advocacy, sustained investment and equitable access. This month’s roundup highlights key prevention news, developments and takeaways from AVAC and explores what’s needed and what’s next to ensure the latest innovations move beyond headlines and into the hands of the communities that need them most.

Prevention Option:

Topic:

August 2026

The State of HIV Prevention: Big News, Big Moves: Reflections from AIDS 2026 in Rio de Janeiro, Brazil 

At AIDS 2026 in Rio de Janeiro, there were difficult conversations around tensions playing out over the future of the AIDS response and the role of USG; big science across HIV prevention, treatment and cure; and strong advocacy calling for greater access, scale and speed for available products. AVAC’s Grace Kumwenda reflects on the conversations and news out of Rio, including big questions that will continue to inform AVAC’s work: What does this actually mean for people and the People’s Research Agenda? What does it mean for the field and the future?

Prevention Option:

Topic:

August 2026

Announcing AVAC’s 2026 HIV Cure Academy Alumni Fellows 

AVAC is pleased to announce the 2026 Alumni Fellows from the HIV Cure Academy Program. This year, five alumni are putting what they gained through the Academies into action—strengthening community engagement, informing policy and advancing HIV cure research in diverse settings across Africa and the US. These grants build on a growing network of Cure Academy alumni who are translating what they learn into meaningful advocacy and action in their communities. Read on to learn more about the 2026 Cure Fellows and their projects and check back throughout the year for updates on their work to advance HIV cure research.

 

Prevention Option:

Topic:

August 2026

Global Health Watch: Exec Order Changes Childhood Vaccine Recs, $2B in Faith-based Aid, NIH Restricts Policy Rx

This week, the US Administration announced $2 billion in global health funding for faith-based organizations; US Congress intensified oversight of PEPFAR and the bilateral global health agreements; the NIH moves to restrict policy-focused research; and – perhaps most alarmingly – the US President issued an executive order rewriting longstanding, evidence-based childhood vaccine recommendations.

Prevention Option:

Topic:

August 2026

Global Health Watch: Fauci in Contempt + New NIAID Director, Senate Blocks OMB’s Grant Proposal, New CDC Director, AIDS 2026 Highlights

This week, the US Senate Committee on Homeland Security & Governmental Affairs voted along party lines to hold Anthony Fauci in contempt of Congress for his refusal to answer questions during last week’s hearing on the COVID-19 response testimony – while it was rumored that Steven Quay, a lab-leak proponent, is in line for Fauci’s old job. At the same time, the US Senate Appropriations Committee did step up to stop the White House OMB’s politicization of federal research grants. There’s also – finally – a new leader of the US Centers for Disease Control and Prevention (CDC). And the HIV/AIDS community is unpacking major themes emerging from the AIDS 2026 conference.

Prevention Option:

Topic:

August 2026

AVAC Says Stop the Waste, Fraud and Abuse in the Persecution of Tony Fauci 

AVAC vehemently opposes the decision by the U.S. Senate Homeland Security and Governmental Affairs Committee to hold Dr. Anthony Fauci in contempt for his refusal to answer questions during last week’s hearing on the COVID-19 response. Certain members of the committee have made clear their intentions to pin the shortcomings of the U.S. response to COVID-19 on others by blaming and dragging renowned government scientists and public health practitioners such as Dr. Fauci through politicized proceedings without any evidence and using conspiratorial conjecture.

August 2026

Beyond AIDS 2026: AVAC’s Top 10

Following the AIDS 2026 conference in Rio de Janeiro, our team compiled a list of AVAC’s top 10 takeaways. These topics sparked discussions and ideas among our team and AVAC’s larger partner network, and will carry our work well into the future.

Prevention Option:

Topic:

August 2026

AIDS 2026: Rising Above to Meet the Moment 

Following AIDS 2026 in Rio de Janeiro, AVAC’s Executive Director Mitchell Warren reflects on a week of conversations, sessions, and new data. As he puts it, Rio was a reminder that science has never been stronger, communities have never been more ready, and the need has never been more urgent. Ending HIV is no longer limited by what we know, it is limited only by the courage to act.

Prevention Option:

Topic:

August 2026

showing 1-10 of 1259

Explore More News and Communications

P-Values Blog

Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.

Advocates Network

AVAC’s email list for organization and individuals interested in timely updates and critical perspectives on developments in biomedical HIV prevention.

Weekly News Digest

A comprehensive round-up of HIV prevention media coverage and scientific publications.

PxPulse

Each month this podcast uses interviews, discussion and first-person reflections to explore vital topics confronting the field of HIV prevention research.

PxWire

PxWire is AVAC’s quarterly update on biomedical HIV prevention. Each issue highlights key developments, challenges and opportunities, and features a centerspread infographic that provides a visual tool for framing these issues.

Pandemic Watch

Pandemic Watch is a curated news digest on the latest pandemic prevention, preparedness, and response (PPPR) news and resources.

Press Releases

A collection of official statements from AVAC.

AVAC in the News

Media clippings featuring AVAC, its staff and close partners in the news media.